39 active compounds across metabolic, neuropeptide, immune, mitochondrial, and tissue repair categories. Each listing includes verified CAS number, molecular weight, and full research context.
A small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in metabolic regulation and adipogenesis. Research has focused on its role in modulating NAD+ metabolism, adipocyte differentiation, and obesity-related cellular pathways in vitro.
A synthetic peptide fragment of human growth hormone (hGH176–191). Studied for its role in stimulating lipolysis and inhibiting lipogenesis in adipocyte cell models, operating independently of insulin-like growth factor (IGF-1) activity.
A non-haematopoietic erythropoietin analogue engineered to selectively activate the innate repair receptor (IRR). Research has examined its cytoprotective and anti-inflammatory properties in peripheral nerve fibre and small fibre neuropathy models.
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal gland peptide epithalamin. Research has focused on its reported capacity to stimulate telomerase activity and extend telomere length in somatic cells, alongside studies examining its antioxidant and anti-ageing properties.
A naturally occurring copper complex of the tripeptide Gly-His-Lys, found in human plasma. Extensively researched for its role in wound healing, collagen and elastin synthesis stimulation, anti-inflammatory signalling, and dermal fibroblast activation in cell culture models.
A tripeptide (Lys-Pro-Val) representing the C-terminal active sequence of alpha-melanocyte stimulating hormone (α-MSH). Research has demonstrated potent anti-inflammatory properties through interaction with the melanocortin-1 receptor (MC1R) in gut epithelial and immune cell assay models.
A mitochondrial-derived peptide encoded within the 12S rRNA gene of mitochondrial DNA. Research has focused on its role in activating AMP-activated protein kinase (AMPK), improving insulin sensitivity, and modulating metabolic homeostasis in skeletal muscle cell models.
A fundamental coenzyme present in all living cells, central to redox reactions and energy metabolism. Research has examined its role in sirtuin pathway activation, mitochondrial biogenesis, DNA repair mechanisms, and age-related metabolic decline in cellular models.
A nonapeptide hormone synthesised in the hypothalamus. Research in cellular and animal models has examined its role in social bonding, stress attenuation, anti-inflammatory signalling, and oxytocin receptor (OXTR) mediated pathways in neural and peripheral tissue.
A synthetic peptide fragment of spadin, derived from the propeptide of neurotensin receptor 3 (NTSR3/sortilin). Research has focused on its inhibition of TREK-1 potassium channels and its antidepressant-like effects via BDNF-TrkB signalling pathways in neuronal models.
A synthetic peptide tri-agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Research has examined its superior efficacy in reducing body weight and improving glycaemic control compared to dual or single receptor agonists in metabolic disease models.
A cell-permeable, mitochondria-targeted tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) that selectively concentrates in the inner mitochondrial membrane. Research has focused on its cardiolipin-binding properties, reduction of reactive oxygen species, and cytoprotective effects under oxidative stress conditions.
A synthetic heptapeptide analogue of the adrenocorticotropic hormone fragment ACTH(4-7), with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Research has examined its capacity to upregulate BDNF expression, enhance dopaminergic and serotonergic signalling, and exhibit neuroprotective properties in cortical cell models.
A 28-amino acid peptide originally isolated from thymosin fraction 5 of bovine thymus. Research has focused on its capacity to modulate T-cell differentiation, stimulate dendritic cell maturation, and enhance toll-like receptor (TLR) signalling pathways in immune cell culture models.
A synthetic heptapeptide analogue of the endogenous immunomodulatory peptide tuftsin, with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Research has focused on its anxiolytic properties, modulation of GABA-A receptor activity, upregulation of BDNF expression, and nootropic signalling mechanisms in neuronal cell models.
A cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH). Research has examined its role as a non-selective agonist at melanocortin receptors (MC1R–MC5R), with studies focusing on melanogenesis, pigmentation pathways, and central nervous system melanocortin signalling mechanisms in cellular models.
A cyclic peptide (bremelanotide) derived from Melanotan-2, functioning as a non-selective melanocortin receptor agonist with primary activity at MC3R and MC4R in the central nervous system. Research has examined its role in neuroendocrine signalling and hypothalamic pathway activation in preclinical models.
Delta sleep-inducing peptide — a nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) isolated from rabbit brain. Research has focused on its modulatory effects on slow-wave sleep, NMDA receptor interactions, glucocorticoid-related pathways, and potential anticarcinogenic and geroprotective properties in cellular and animal models.
A synthetic pentadecapeptide (15 amino acids) derived from human gastric juice protein BPC. One of the most extensively researched repair peptides, with studies examining nitric oxide pathway modulation, VEGF-mediated angiogenesis, growth factor upregulation, and cytoprotective effects in gastrointestinal, musculoskeletal, and neural tissue models.
A synthetic 43-amino acid peptide corresponding to the full sequence of Thymosin Beta-4, an actin-binding protein ubiquitous in human and animal cells. Research has focused on its role in cytoskeletal dynamics via G-actin sequestration, cell migration, angiogenesis, and wound healing in cardiac, muscular, and corneal tissue models.
A 29-amino acid synthetic analogue of growth hormone-releasing hormone (GHRH 1-29), also referred to as ModGRF(1-29). Research has examined its role as a short-acting GHRH receptor agonist, stimulating pulsatile growth hormone secretion from pituitary somatotrophs in a physiologically mimetic pattern in cell and animal models.
A modified form of CJC-1295 incorporating a Drug Affinity Complex (DAC) lysine modification that enables covalent binding to serum albumin, extending plasma half-life significantly. Research has focused on its sustained GHRH receptor stimulation and prolonged elevation of GH and IGF-1 in preclinical secretagogue studies.
A 344-amino acid isoform of follistatin, a naturally occurring glycoprotein that binds and neutralises members of the TGF-β superfamily, including activin, myostatin (GDF-8), and BMP ligands. Research has focused on its role in inhibiting myostatin-mediated muscle atrophy signalling and modulating reproductive axis FSH suppression in cellular models.
A synthetic 44-amino acid analogue of human GHRH conjugated to a trans-3-hexenoic acid group at its N-terminus, enhancing metabolic stability. Approved (Egrifta) for HIV-associated lipodystrophy research. Studies have examined its role in pulsatile GH release, IGF-1 elevation, and visceral adipose tissue reduction mechanisms in metabolic models.
A copper-complexed tripeptide with the sequence Ala-His-Lys, structurally related to GHK-Cu but with alanine in place of glycine at the N-terminus. Research has focused on its role in copper-mediated wound healing, fibroblast activation, and extracellular matrix remodelling, with particular interest in hair follicle biology and dermal regeneration models.
The 10-amino acid C-terminal bioactive fragment of kisspeptin-54, encoded by the KISS1 gene. Functions as an endogenous ligand for the GPR54/KISS1R receptor. Research has examined its role as a potent stimulator of GnRH release, gonadotropin regulation, and reproductive axis modulation in hypothalamic and pituitary cell models.
A low-molecular-weight peptide complex isolated from bovine thymus gland, primarily studied for its immunomodulatory and geroprotective properties. Research has examined its role in stimulating T-cell differentiation, normalising Th1/Th2 cytokine balance, and extending lifespan in ageing animal models. Associated with the Khavinson longevity peptide research programme.
A D-retro-inverso isoform of a cell-penetrating peptide targeting the FOXO4–p53 protein interaction in senescent cells. Research has demonstrated selective induction of apoptosis in senescent but not healthy cells by disrupting FOXO4-mediated p53 nuclear sequestration, restoring p53-directed programmed cell death in preclinical ageing models.
A 37-amino acid cationic antimicrobial peptide derived from the C-terminal domain of human cathelicidin protein hCAP18. The only known human cathelicidin peptide. Research has focused on its broad-spectrum antimicrobial activity, innate immune modulation, TLR4 ligand interactions, wound healing promotion, and angiogenic properties in cellular and infection models.
Vasoactive Intestinal Peptide — a 28-amino acid neuropeptide widely distributed in the central and peripheral nervous systems. Research has examined its role as a potent vasodilator and smooth muscle relaxant operating through VPAC1 and VPAC2 receptors, with additional studies focusing on immunomodulation, circadian rhythm regulation, and anti-inflammatory signalling in neuroendocrine models.
A synthetic small molecule agonist of oestrogen-related receptors ERRα, ERRβ, and ERRγ, nuclear receptors involved in mitochondrial biogenesis and oxidative metabolism. Research has focused on its capacity to mimic exercise-like metabolic adaptations including increased fatty acid oxidation, mitochondrial gene expression, and improved aerobic capacity in skeletal muscle cell models.
A synthetic tripeptide (Glu-Asp-Arg) developed from research on pineal gland peptide fractions by the Khavinson Institute of Bioregulation. Research has examined its role in neuroprotection, modulation of melatonin synthesis pathways, antioxidant activity in neural tissue, and gene expression regulation associated with circadian rhythm and ageing in neuronal cell models.
Acetyl Octapeptide-3 — an 8-amino acid N-acetylated peptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asn) representing an analogue of the N-terminal fragment of SNAP-25, a component of the SNARE complex involved in neurotransmitter vesicle docking. Research has focused on its inhibition of SNAP-25 mediated acetylcholine release at neuromuscular junctions in in vitro models.
A synthetic pentapeptide (Aib-His-D-2Nal-D-Phe-Lys-NH2) and selective ghrelin receptor (GHSR-1a) agonist. Extensively studied for its selective stimulation of growth hormone release from pituitary somatotrophs, notably without significant co-stimulation of cortisol, ACTH, or prolactin — making it a clean tool for studying the GH secretagogue axis in research models.
A synthetic 29-amino acid amide corresponding to the biologically active N-terminal fragment of endogenous human growth hormone-releasing hormone (GHRH 1-29). The shortest GHRH fragment retaining full receptor-binding activity. Research has examined its pulsatile stimulation of GH secretion, diagnostic utility in GH deficiency assessment, and downstream IGF-1 regulation in pituitary cell models.
A proprietary multi-peptide research blend formulated for in vitro cellular repair and regeneration studies. Contains a curated combination of tissue-repair and anti-inflammatory peptides. Contact for full compound disclosure and research applications.
A proprietary multi-peptide research blend formulated for in vitro immunomodulation and anti-inflammatory pathway studies. Contains a curated combination of repair and immune-modulating peptides. Contact for full compound disclosure and research applications.
A recombinant fusion protein combining the extracellular domain of activin receptor type IIB (ActRIIB) with a human IgG1 Fc region. Research has focused on its role as a soluble decoy receptor that sequesters myostatin and other TGF-β ligands, inhibiting muscle atrophy signalling in neuromuscular disease research models.
A naturally occurring tripeptide (Gly-Cys-Glu) and the most abundant intracellular antioxidant in mammalian cells. Research has focused on its central role in redox homeostasis via the GSH/GSSG cycle, detoxification of reactive oxygen species, phase II xenobiotic metabolism, and modulation of immune signalling and apoptotic pathways in cellular models.